1. |
Vionnet J, Sempoux C, Pascual M, et al. Donor-specific antibodies in liver transplantation. Gastroenterol Hepatol, 2020, 43(1): 34-45.
|
2. |
Taner T, Stegall MD, Heimbach JK. Antibody-mediated rejection in liver transplantation: current controversies and future directions. Liver Transpl, 2014, 20(5): 514-527.
|
3. |
董辉, 丛文铭. 肝移植后抗体介导性排斥反应的进展. 中华器官移植杂志, 2014, 35(8): 509-511.
|
4. |
Youn JC, Zhang X, Nishihara K, et al. Post-transplantation outcomes of sensitized patients receiving durable mechanical circulatory support. J Heart Lung Transplant, 2022, 41(3): 365-372.
|
5. |
Lubetzky M, Hayde N, Broin PÓ, et al. Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibody. Clin Transplant, 2019, 33(3): e13469.
|
6. |
Madill-Thomsen KS, Böhmig GA, Bromberg J, et al. Donor-specific antibody is associated with increased expression of rejection transcripts in renal transplant biopsies classified as no rejection. J Am Soc Nephrol, 2021, 32(11): 2743-2758.
|
7. |
Stegall MD, Diwan T, Raghavaiah S, et al. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant, 2011, 11(11): 2405-2413.
|
8. |
Del Bello A, Congy-Jolivet N, Danjoux M, et al. De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients. Transpl Int, 2015, 28(12): 1371-1382.
|
9. |
Maurice JB, Nwaogu A, Gouda M, et al. Acute antibody-mediated rejection in liver transplantation: impact and applicability of the Banff working group on liver allograft pathology 2016 criteria. Hum Pathol, 2022, 127: 67-77.
|
10. |
Sakamoto S, Akamatsu N, Hasegawa K, et al. The efficacy of rituximab treatment for antibody-mediated rejection in liver transplantation: a retrospective Japanese nationwide study. Hepatol Res, 2021, 51(9): 990-999.
|
11. |
Kamada N, Calne RY. Orthotopic liver transplantation in the rat: technique using cuff for portal vein anastomosis and biliary draninage. Transplantation, 1979, 28(1): 47-50.
|
12. |
赵姣姣, 莽源祎, 李立, 等. 大鼠原位肝移植模型不同灌注方式和吻合方法的效果比较. 中国普外基础与临床杂志, 2023, 30(5): 549-553.
|
13. |
Demetris AJ, Bellamy C, Hübscher SG, et al. 2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection. Am J Transplant, 2016, 16(10): 2816-2835.
|
14. |
陈栋, 魏来, 蒋继贫, 等. 肝移植后急性体液性排斥反应的诊断和治疗两例. 中华器官移植杂志, 2014, 35(8): 451-454.
|
15. |
Lee M. Antibody-mediated rejection after liver transplant. Gastroenterol Clin North Am, 2017, 46(2): 297-309.
|
16. |
Mang Y, Zhang S, Zhao J, et al. Characteristics of pre-sensitization-related acute antibody-mediated rejection in a rat model of orthotopic liver transplantation. Ann Transl Med, 2022, 10(19): 1066. doi: 10.21037/atm-22-4311.
|
17. |
Petty M. Antibody-mediated rejection in solid organ transplant. AACN Adv Crit Care, 2016, 27(3): 316-323.
|
18. |
Ono K, Ide K, Tanaka Y, et al. Molecular mismatch predicts T cell-mediated rejection and de novo donor-specific antibody formation after living donor liver transplantation. Liver Transpl, 2021, 27(11): 1592-1602.
|
19. |
Astarcioglu I, Cursio R, Reynes M, et al. Increased risk of antibody-mediated rejection of reduced-size liver allografts. J Surg Res, 1999, 87(2): 258-262.
|
20. |
Ueda H, Itoh S, Iwamoto Y, et al. Sensitization interval and administration method alter the effect of 15-deoxyspergualin on heart transplantation in sensitized recipient rats. Transpl Int, 1996, 9(6): 551-556.
|
21. |
Stadlbauer TH, Faske R, Heidt MC, et al. Apoptotic cell death during accelerated rejection in sensitized rat recipients of cardiac allografts. Transplant Proc, 2009, 41(6): 2621-2624.
|